chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He had the strength in his legs to be able to stand up without pushing himself up, something he has not been able to do for some time (uses wheelchair and lift chair); He got sick; This is a spontaneous report from a Pfizer-sponsored program reported from a contactable consumer (patient's spouse). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number was not reported) as dose 2, single for COVID-19 immunization. The patient medical history included multiple sclerosis (ongoing) and wheelchair user (ongoing). Concomitant medications were not reported. The patient got sick for 24 hours after receiving 2nd injection like many others. 24 hours later, patient was just fine. However, he had the strength in his legs to be able to stand up without pushing himself up. It was some-thing he has not been able to do for some time (uses wheelchair and lift chair). The reporter stated that this was a huge surprise. It lasted for 5 days and was very nice little side effect even if it lasted only 5 days. The outcome of sickness was recovered.  Information regarding the lot/batch number has been requested.
Form initial information received on 18NOV2003 form the patient's wife regarding an adverse event occurring in the USA , it was reported that a 64 year old male patient received a dose of FLUZONE SV 2003-2004 USP and a dose of Pneumococcal Vaccine on 9OCT2003. The following day, the patient developed muscle aches and pains that have gotten progressively worse since the onset date. The patient was evaluated by six doctors including an internist, pulmonologist, gastroenterologist, neurologist, cardiologist, and rheumatologist. There is no confirmed diagnosis. The patient's blood work revealed elevated WBC and elevated CPK. An echocardiogram, muscle function testing, chest x ray, EMG and autoimmune tests were all normal. At the time of this report, the patient had nor recovered.
20MAR 230AM to 4AM crying, jerky, temp 103ax, APAP brought temp down;
Patient's wife reported she believes the flu shot he received caused the patient to become very sick resulting in pneumonia and an extended hospital stay. She also reported that his left arm was still hurting. He received vaccination in right arm. Once told this she stated both arms hurt.
elevated blood sugars; continues to feel cold; Joint pain in knees; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Knee replacement. Concomitant products included PROBIOTICS NOS, AZATHIOPRINE SODIUM (IMURAN [AZATHIOPRINE SODIUM]), SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]) and GLYBURIDE for an unknown indication.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills). At the time of the report, HYPERGLYCAEMIA (elevated blood sugars), FEELING COLD (continues to feel cold), ARTHRALGIA (Joint pain in knees) and CHILLS (Chills) outcome was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.    No treatment information was provided.
Red, very itchy, swollen area  2-3 inches in diameter surrounding injection site. First injection reaction cleared in 3 days. Second shot injection was initially red, itchy, swollen, warm to touch from 3 days after shot until 14 days after shot. During that time, I had other areas on my body that also felt itchy but were not red. The size of the reaction on the second shot was twice as large as for the first shot.
Awoke with a fever at 2 am, 15 hours after receiving my second vaccination. Other symptoms were severe headache behind my eyes, weakness, dizziness, diarrhea and lethargy. Temperature was 101.8 F. Slept on and off all day, it seemed, took Advil. When I woke on Saturday around 4 pm, I could tell my fever was gone. Took my temp again and it was down to 97F.  Still had headache but it was milder. Stayed home, resting the rest of Saturday and Sunday, even though it was Easter and really wanted to see some family members.
Mother states patient left arm swelled with itching for 3 days on 07/14/2005.  Patient had immunization and had reaction right away.  Left deltoid was red and swollen
patient received Fluzone Quad and Arexvy in left arm (flu vaccine higher / RSV lower part of muscle) on Monday, Starting Tuesday morning patient had Fever, chills, Thurs redness started at injection site, and by Friday the area was hot, wet, swollen. Patient went to Urgent Care and was diagnosed with Cellulitis
I did not have an adverse reaction to the vaccine. I have had full body joint pain since the fall of 2022. The symptoms just got worse, and I had an appointment with my doctor who referred me to a rheumatologist. I was diagnosed with rheumatoid arthritis on 04/26/2023. I am currently in treatment.
A solicited report has been received from a Health Professional enrolled in non-interventional/post-marketing study, concerning herself, who had been receiving Nasal FLUMIST Quadrivalent for patient exposed to FLUMIST while administering it. FLUMIST Quadrivalent started on an unknown date for patient exposed to FLUMIST while administering it. The nurse reported that she was feeling sick today and every time she administered FLUMIST she got sick. The first time she administered it within a week, she got a cold but normally she does not get cold easily. Then after 6 weeks, within 6 hours administering it again she started getting cold. The outcome of the event of the first time she administered it within a week, she got a cold but normally she doesn't get cold easily/within 6 hours administering it again she started getting a cold and every time she administers FLUMIST she gets sick is unknown. The report was considered to be non-serious. Based on the information in this report, and awaiting the reporter's assessment, the company physician considered the events every time she administers FLUMIST she gets sick and the first time she administered it within a week, she got a cold but normally she doesn't get cold easily/within 6 hours administered it again she started getting a cold with the suspect drug of FLUMIST quadrivalent to be related.
52 year old man with a history of Hodgkins disease and T cell, B cell rich lymphoma, coronary artery disease, valve replacement, developed thrombocytopenia approximately one week after recieving influenza vaccine (2005/6).  The patient presented to our urgent care with a platelet count of "9".  Patient experienced dyspnea & elevated BP.  Patient received IVIG, platelet transfusions and was put on prednisone. Discharge summary states idiopathic thrombocytopenia purpura. msv
A report has been received from a Health Professional concerning a 17 year old, female subject, who had been receiving Nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. It was reported that patient was administered an expired FLUMIST which started on 30-DEC-2014. The outcome of the event of expired FLUMIST Quadrivalent administered is unknown. The report was considered to be non-serious. Corrected report 21-OCT-2015: Key ingredient updated.
This spontaneous report was received from a healthcare worker referring to an unspecified patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, in November 2015, was administered to the patient an expired dose of ZOSTAVAX (lot # K010967, expiry date 06-NOV-2015). Other co-suspect or concomitant medications were not reported. No adverse effects reported. Additional information has been requested.
Emesis multiple x Fri and Sat, loose green stool. Emesis 1x daily for 3 days. Seen in office on 2/28/14 Dx Gastroenteritis, GERD (reaction to shot). Script for Ranitidine for 2 wks. Parents and siblings had aches, pains and stomach issues x 1 day.
"Brain Fog"; Difficulty Concentrating; Difficulty Focusing; Difficulty Finding Words when Trying to Speak; Waves of Fatigue
Post vax, pt began to break out in red, splotchy hives (flat), started on chest, progressed up to neck, then on arms, and rest of torso. Patient had exact same reaction previously when receiving vax. The reaction was attributed to Varivax as the rash started at the Varivax injection site. Sent to emergency and released.
pt recvd vax stated wife has recvd shot 1OCT93; following shot began not feeling well & subsequently pneumonia; in critical condition on vent;
COVID vaccination clinic received Pfizer vaccination at 1015, started with shortness of breath and a different feeling in her chest at 1022. Removed mask, inspected oral airway, no swelling noted. Individual talking and answering questions. BP 138/68, pulse 78, respiratory rate 20, oxygen sat 96% RA. Benadryl 25 mg orally administered 1025. Remained at bedside, granddaughter also at bedside. 1031 verbalizes feeling better. 1033 pulse 61, Pulse Ox on room air 98%. verbalizing wanting to leave, go home.  1045 left with granddaughter.
I had a bad cold that started in Christmas time and that never went away. It turned into pneumonia and I was septic and I was taken to the hospital in March. I was taken to an urgent care a day before that and I was prescribed antibiotics. I took one dose and became really sick during the night. Emergency help came and took me to the hospital. I had 104 fever and a bad cough. X-rays at the hospital showed the lungs were filled with pneumonia. The EKG showed that I had afib. I got new medications after being discharged from the hospital. It was benzonatate, metoprolol, and ELIQUIS. I also used an albuterol inhaler.
Severe chest pressure, headache, fever, chills, fatigue, body aches.  Treated at medical facility and diagnosed with pericarditis after EKG and heart cath, due to symptoms of heart attack.
Initial unsolicited case received from an other healthcare professional on 11-AUG-2017. This case involves two patients (age and gender not reported) who was vaccination with a dose of FLU VACCINE (Batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. Patient's Illness at time of vaccination, Pre-existing physician diagnosed allergies, birth defects, medical conditions and concomitant medications were not reported. On an unknown date, following the flu vaccination, the patients developed Guillain-Barre syndrome (GBS). The reporter did not know the names of the 2 employees, did not know dates of vaccination, did not know what brand of flu vaccine the 2 employees had received, and did not know how long after vaccination the 2 employees experienced GBS. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. Upon internal review, the company decided to consider the event serious because of important medical event: Guillain Barre syndrome. List of documents held by sender: none. Sender's Comments: In this case, the symptoms and evolution of GBS (Guillain Barre Syndrome) has not been reported. The time to event onset post vaccination was unknown. The manufacturer of the influenza vaccine was not reported. Further information regarding GBS diagnosis confirmation (cerebrospinal fluid and electrophysiological analyses, absence of tendon reflexes, information on limbs weakness, information on the development of the disease i.e. monophasic pattern or not), vaccine details and infectious work up to confirm the absence of concurrent infection are needed for complete assessment of the case.
left hand numbness, question Gullian Barre Syndrome.  09/12/2007 MR received for OV 8/30/2007 for c/o finger numbness x several weeks.  Finger numbness began ~20 days s/p Gardasil vax.  No trauma.  Numbness noted in 4th and 5th fingers which spread down into lateral hand.  Currently only in 5th finger and tip of 4th. PE (+) for decreased sensation to light touch and pin prick in R 5th finger. Otherwise WNL. Impression:  Neuropathy, Idiopathic Peripheral NOS.  Uncertain if very mild Guillain-Barre Syndrome from Gardasil vaccine.
Couldn't sleep on arm it was raised, next day had chills, felt bad, had redness around injection site with pain. 5.75 x 4.25 area of erythema and warmth. Did take BENADRYL and now taking Sulfamethoxazole-Trimethoprim.
18 YO patient received adult dose; 18 YO patient received adult dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 18-year-old female patient who received HBV (Engerix B adult) (batch number M4KE9, expiry date 29th April 2023) for prophylaxis.   On 23rd May 2022, the patient received the 1st dose of Engerix B adult. On 23rd May 2022, unknown after receiving Engerix B adult, the patient experienced overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the overdose and inappropriate age at vaccine administration were unknown.   Additional Information: GSK receipt date: 23-May-2022 Reporter's comment: The health care professional reported that a patient of 18-year-old patient was administered adult dose of Engerix B (1 month prior to the reporting). The health care professional also stated that this was the first dose of the series of Engerix B and they wanted to give the appropriate dose to the patient. Asked how we should proceed. The reporter consented to follow up. Additional Supportive Information: The patient of 18-year-old patient was administered adult dose of Engerix B, which led to overdose and inappropriate age at vaccine administration.
Headache; her legs are weak; This case was reported by a consumer via call center representative and described the occurrence of headache in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th July 2021, the patient received the 1st dose of Shingrix (intramuscular). In July 2021, less than 3 weeks after receiving Shingrix, the patient experienced headache and lower extremities weakness of. On an unknown date, the outcome of the headache and lower extremities weakness of were not recovered/not resolved.   It was unknown if the reporter considered the headache and lower extremities weakness of to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient for herself. The patient stated that she received dose of Shingrix and had a headache everyday and also her legs were weak on occasion since taking the shot. The reporter did not consent to follow up.
Muscle Cramping; This is a spontaneous report from a contactable consumer. A 64-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EP7533), dose 2 intramuscular, administered in Arm Right on 24Mar2021 at 16:40 (at the age of 64 year) as dose 2, single for COVID-19 immunisation. Medical history included leg pain and headache. Patient did not receive prior vaccinations within 4 weeks. Concomitant medication(s) included tramadol taken for leg pain, headache from 19Apr2021 and ongoing; baclofen taken from 01Apr2021; zolpidem taken from 17Mar2021; olmesartan taken from 02Nov2020; diclofenac sodium taken from 06May2020; vitamin b complex taken from 25Feb2020; aspirin [acetylsalicylic acid] taken from 11Jan2020; Dietary Supplement taken from 06May2020. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/lot number: BioNTech/EN6204), dose 1 Intramuscular on 03Mar2021 at 16:40 for COVID-19 immunisation and experienced Headache. On 01Apr2021, patient experienced muscle cramping. AE required visit to Physician office. The patient underwent lab tests and procedures on an unspecified date which included MRI and other testing and all was okay. Therapeutic measures were taken as a result of muscle cramping which included treatment Baclofen, couldn't take due to drowsy. The outcome of event was recovering.  Follow-up attempts are completed. No further information is expected.
Information has been received from a medical assistant concerning an approximately 17 year old female with allergy to FLONASE who in April 2008, was vaccinated with the first 0.5 mL dose of GARDASIL vaccine. Concomitant therapy included diclofenac. The patient complaint of pain during administration of her first dose. The outcome was not reported. The patient sought unspecified medical attention during office visit. Additional information has been requested.
1 week after receiving vaccine, my arm has slightly swelled, and turned red, though not hot to the touch, and is very itchy.
no additional adverse event reported; ROTATEQ was administered to a patient today 12Jul2022 and the patient was 12 weeks and 1 day old; This spontaneous report was received from a physician and refers to a 12-week-and-1-day-old patient of unknown gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.  On 12-JUL-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, first dose, lot #1837118, expiration date: 25-MAR-2023, administered orally (strength was not provided) for prophylaxis (Product administered to patient of inappropriate age). No adverse events were reported (No adverse event).
Child admitted to hospital with aseptic meningitis 3 days after receiving MMR, Hib and hep B #2. Developed fever 1 day after received vaccine. Follow up on 05/11/04: "No prior vaccinations after adverse events."  Nurse follow up on 07/19/04 states: "Viral meningitis."
Case number PHEH2015US020587 is an initial spontaneous report received from a nurse on 13 Oct 2015. This report refers to a 35 year old female patient. Medical history and concomitant medication were not reported. The patient was vaccinated with an expired dose of FLUVIRIN (batch number: 1412701) at a dose of 0.5 ml, intramuscularly on 08 Oct 2015. No adverse event was reported following this medication error (expired vaccine used).
STAGE 4 LARYNX CANCER; COMPROMISED IMMUNE SYSTEM; TERRIBLE INCURABLE COLDS; INFECTION; This spontaneous report received from a consumer via social media via company representative concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient was previously treated with covid-19 vaccine ad26. cov2. s (unspecified manufacturer) (Dose number in series 1) (suspension for injection, route of admin, and batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis.  It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s.(Dose number in series 1) The patient additionally received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 01 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced stage 4 larynx cancer, compromised immune system, terrible incurable colds and infection. (Dose number in series 2) Reporter stated that, "My mother had all the recommended COVID vaccines and boosters per requirements of her job, which in turn compromised her immune system, dealt with terrible incurable colds and infection and is currently battling stage 4 larynx cancer. I never had any vaccines and I have been fine, had COVID with very mild symptoms. I'd love to learn more about your research" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from stage 4 larynx cancer, and the outcome of compromised immune system, terrible incurable colds and infection was not reported. This report was serious (Other Medically Important Condition). This case is a duplicate of 20221240499 and 20221240550. This case, involving the same patient is linked to 20221240593 (Dose number in series 1)  It was determined that manufacturer Case Number 20221240499 and 20221240550 were duplicate of this case. All relevant information regarding this case will be submitted under manufacturer Case Number 20221239600.; Sender's Comments: V0-20221239600- Stage 4 larynx cancer- The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the Causality is considered indeterminate. The company causality is considered unassessable.
Severe bodyache with joint pain severe (Knee pain and upper back), chills, headache but more pain in  right side headache with right ear tinnitus, sometimes cough, runny nose and metal taste in mouth.
I had got exposed to my COVID-19 positive wife. I was to have an appointment with my doctor and tested positive at home. I was prescribed PAXLOVID. I lost 95% of my taste and smell. I felt just as if I had a really bad cold. It was mild for the most part. I had a slight sore throat, running nose and a slight headache in the beginning. I had upper chest congestion and cough that latest a week. It was four days of sinus congestion; the rest was in my upper chest. I still have a chest cough, but other than that I feel fine.
Headache, Chills, Nausea, Fatigue, Muscle Aches.  I slept for approximately 18 hours with really bad chills.
Incorrect Moderna vaccine administered. For 2nd dose in series and CDC recommendations patient should have received Moderna dark blue cap/gray label as her 2nd dose.  Patient experienced no side effects. Family aware of error and recommendation to repeat with additional dose. Vaccine administered by,CMA.  VAERS completed by CMA.
pt recvd vax 11AM on 26SEP95 & returned to office w/in 45mins c/o febrile to 105.3, chills, very fussy, clammy w/mottled skin;escorted to ER by MD;adm to hosp x 24hrs;
Pt got Tdap in right arm and SHINGRIX in upper right arm/FLUZONE lower right deltoid on 8/11. On 8/13, she returned to pharmacy to show pharmacist her arm. The SHINGRIX site had a ring around the injection site, was red and swollen, approximately half dollar-size, (normal, expected side effect). The FLUZONE injection site was more inflamed, and had a softball-sized ring around the injection site (still a more severe, but expected side effect).
Information has been received from a physician concerning a 26 year old female with no pertinent medical history who on 04-OCT-2007 in the a.m. was vaccinated into the left arm with a third dose of HPV rL1 6 11 16 18 VLP (yeast) (Lot #0530U). There was no concomitant medication. On 04-OCT-2007 the patient developed redness and swelling of the left arm around the injection site. There were no laboratory or diagnostic tests performed. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Rn called patient with lab results. Patient reported severe pain at injection site. Recommended heat pack and acetaminophen. Pain less next day.
Information has been received from a registered nurse who stated that a nurse practitioner informed her about an adult patient who on an unspecified date was possibly vaccinated with more that 1 dose of MMR II but still had negative titers. It was unspecified if the patient sought medical attention. At the time of report, the patient had not recovered. Attempts are being made to verify the existence of an identifiable source.